| Next 10 |
Ad
AMPH News and Press Amphastar Pharmaceuticals Inc.
News | Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH)
- AMPH - Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wedn...
-
2025-02-27 23:04:02 ET Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Conference Call February 27, 2025 17:00 ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications William Peters - Chief Financial Officer & Executive Vic...
-
2025-02-27 16:26:12 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals: A Gradual Strategy Amphastar Pharmaceuticals: Cheap With Caveats Amphastar Pharmaceuticals Q4 2024 Earnings Preview Seeking Alpha’s Quant Rating on Amphastar Pharmaceut...
-
Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024 RANCHO CUCAMONGA, CA / ACCESS Newswire / February 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full year ended Dec...
-
FTAI Infrastructure Inc. (FIP) is expected to report for quarter end 2024-12-31 Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.16 for Q4 2024 Falconstor Software Inc (FALC) is expected to report for quarter end 2024-12-31 Payoneer Global Inc. (PAYO) is expected to report...
-
2025-02-26 17:20:16 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals: A Gradual Strategy Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha’s Quant Rating on Amphastar Pharmaceuticals Historical earnings data for Amphastar Pharma...
-
2025-02-25 18:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its Fourth quarter of 2024 ended December 31, 2024, after the market closes on Thursday, February 27, 2025, and will hold a confere...
-
2025-02-19 13:09:18 ET Summary Amphastar Pharmaceuticals has a growth model based on organic growth and acquisitions, though competition and patent expirations pose risks. Financially, Amphastar has a strong revenue trend but faces potential growth slowdowns, especially in 2025. ...
-
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15 th , 2025, at 11:15 am PST...
Stock Information
Get AMPH Alerts
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
0.69% G/L:
$27.36 Last:
602,473 Volume:
$27.50 Open:
$27.36 Close:
Amphastar Pharmaceuticals Inc. Website:
Ad
- AMPH - Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wedn...
-
Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024 RANCHO CUCAMONGA, CA / ACCESS Newswire / February 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full year ended Dec...
-
FTAI Infrastructure Inc. (FIP) is expected to report for quarter end 2024-12-31 Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.16 for Q4 2024 Falconstor Software Inc (FALC) is expected to report for quarter end 2024-12-31 Payoneer Global Inc. (PAYO) is expected to report...